194 related articles for article (PubMed ID: 7511740)
21. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P
J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930
[TBL] [Abstract][Full Text] [Related]
22. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
Malminiemi K; Lahtela JT; Huupponen R
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
[TBL] [Abstract][Full Text] [Related]
23. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Fogari R; Zoppi A; Malamani GD; Marasi G; Vanasia A; Villa G
Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
[TBL] [Abstract][Full Text] [Related]
25. Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure.
Krysiak R; Okopień B
Pharmacol Rep; 2012; 64(6):1466-75. PubMed ID: 23406757
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT
Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621
[TBL] [Abstract][Full Text] [Related]
27. Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertension.
Jandrain B; Herbaut C; Depoorter JC; Voorde KV
Am J Med; 1992 Apr; 92(4B):91S-94S. PubMed ID: 1580288
[TBL] [Abstract][Full Text] [Related]
28. Effects of manidipine and delapril on glucose and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus.
Atarashi K; Takagi M; Minami M; Kimura Y; Matsuoka H; Sugimoto T
Blood Press Suppl; 1992; 3():130-4. PubMed ID: 1343282
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.
Fogari R; Zoppi A; Corradi L; Lazzari P; Mugellini A; Lusardi P
Br J Clin Pharmacol; 1998 Nov; 46(5):467-71. PubMed ID: 9833600
[TBL] [Abstract][Full Text] [Related]
30. Glucose and lipid metabolism during long-term lisinopril therapy in hypertensive patients.
Shionoiri H; Ueda S; Gotoh E; Ito T; Ogihara T
J Cardiovasc Pharmacol; 1990 Dec; 16(6):905-9. PubMed ID: 1704982
[TBL] [Abstract][Full Text] [Related]
31. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic effects of angiotensin-converting enzyme inhibitors in normotensive patients with coronary artery disease.
Krysiak R; Okopień B
Pharmacol Rep; 2008; 60(4):514-23. PubMed ID: 18799820
[TBL] [Abstract][Full Text] [Related]
33. Metabolic effects of enalapril in the treatment of essential hypertension.
Oksa A; Stefíková K; Fedelesová V; Baculáková V; Spustová V; Dzúrik R
Cor Vasa; 1992; 34(4):329-41. PubMed ID: 1308725
[TBL] [Abstract][Full Text] [Related]
34. Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril.
New JP; Bilous RW; Walker M
Diabet Med; 2000 Feb; 17(2):134-40. PubMed ID: 10746484
[TBL] [Abstract][Full Text] [Related]
35. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
Fuh MM; Shieh SM; Wu DA; Chen YD; Reaven GM
Arch Intern Med; 1987 Jun; 147(6):1035-8. PubMed ID: 3296980
[TBL] [Abstract][Full Text] [Related]
36. Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension.
Falkner B; Canessa M; Anzalone D
Am J Hypertens; 1995 May; 8(5 Pt 1):454-60. PubMed ID: 7662220
[TBL] [Abstract][Full Text] [Related]
37. Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril.
Allemann Y; Baumann S; Jost M; Ferrari P; Shaw S; Riesen W; Weidmann P
Eur J Clin Pharmacol; 1992; 42(3):275-80. PubMed ID: 1533588
[TBL] [Abstract][Full Text] [Related]
38. Effect of statin therapy added to ACE-inhibitors on blood pressure control and endothelial functions in normolipidemic hypertensive patients.
Danaoğlu Z; Kültürsay H; Kayikçioğlu M; Can L; Payzin S
Anadolu Kardiyol Derg; 2003 Dec; 3(4):331-7. PubMed ID: 14675884
[TBL] [Abstract][Full Text] [Related]
39. Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients.
Tezcan H; Yavuz D; Toprak A; Akpinar I; Koç M; Deyneli O; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):119-23. PubMed ID: 12806595
[TBL] [Abstract][Full Text] [Related]
40. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
